Potential Drug-Drug Interaction (PDDI) Clinical Decision Support, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: valueset-AAS

Raw json | Download

{
  "resourceType" : "ValueSet",
  "id" : "valueset-AAS",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet valueset-AAS</b></p><a name=\"valueset-AAS\"> </a><a name=\"hcvalueset-AAS\"> </a><p>This value set includes codes based on the following rules:</p><ul/></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-rules-text",
      "valueMarkdown" : "Query NLM RxClass for [Aldosterone Antagonists|MOA](https://mor.nlm.nih.gov/RxClass/search?query=Aldosterone%20Antagonists%7CMOA&searchBy=class&sourceIds=&drugSources=atc1-4%7Catc%2Cepc%7Cdailymed%2Cmeshpa%7Cmesh%2Cdisease%7Cmedrt%2Cchem%7Cdailymed%2Cmoa%7Cdailymed%2Cpe%7Cdailymed%2Cpk%7Cmedrt%2Ctc%7Cfmtsme%2Cva%7Cva%2Cdispos%7Csnomedct%2Cstruct%7Csnomedct%2Ctherap%7Csnomedct%2Cschedule%7Crxnorm#) to identify the class members appropriate for prescribable drug identification. Then use NLM RxMix/RxClass tooling to derive the current RxNorm Semantic Clinical Drug and related prescribable forms needed for implementation."
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode" : "cds"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode" : "informative",
      "_valueCode" : {
        "extension" : [
          {
            "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
            "valueCanonical" : "http://hl7.org/fhir/uv/pddi/ImplementationGuide/hl7.fhir.uv.pddi"
          }
        ]
      }
    }
  ],
  "url" : "http://hl7.org/fhir/uv/pddi/ValueSet/valueset-AAS",
  "version" : "1.0.0",
  "name" : "Valueset_AAS",
  "title" : "Aldosterone Antagonists Drug Value Set",
  "status" : "draft",
  "experimental" : true,
  "date" : "2018-07-02",
  "publisher" : "HL7 International / Clinical Decision Support",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://www.hl7.org/Special/committees/dss"
        }
      ]
    }
  ],
  "description" : "Value set representing the aldosterone antagonist drug class for PDDI CDS. Membership should be maintained using the documented RxClass/RxMix derivation process rather than a locally enumerated expansion.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code" : "001"
        }
      ]
    }
  ],
  "purpose" : "Provide Aldosterone Antagonist drug class terminology for PDDI CDS FHIR resources",
  "copyright" : "(copyright expectations unknown)"
}